The American Hospital Association expresses concern about Eli Lilly’s January 2026 claims-data policy and invites Lilly to work in good faith with the AHA and our 340B hospital members to find a ...

As regulatory scrutiny increases and manufacturer restrictions continue to evolve, Halo 340B provides an intelligent safety net that transforms 340B management from a high-risk administrative burden ...

It's time for lawmakers to finally fix the 340B drug prescription program so it truly benefits our state's most vulnerable ...

Federal judge permanently blocks North Dakota 340B drug law, ruling it unconstitutional and halting enforcement against drugmakers and PhRMA members.

Hospitals are suing to block a Trump administration pilot that will allow drugmakers to issue post-sale rebates instead of upfront discounts on medications in the 340B drug discount program, arguing ...

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.